The latest price target for Dentsply Sirona (NASDAQ:XRAY) was reported by Wells Fargo on February 14, 2025. The analyst firm set a price target for $20.00 expecting XRAY to rise to within 12 months (a possible 6.67% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for Dentsply Sirona (NASDAQ:XRAY) was provided by Wells Fargo, and Dentsply Sirona initiated their equal-weight rating.

The last upgrade for Dentsply Sirona Inc happened on November 10, 2023 when William Blair raised their price target to N/A. William Blair previously had a market perform for Dentsply Sirona Inc.

The last downgrade for Dentsply Sirona Inc happened on January 23, 2025 when Jefferies changed their price target from $30 to $20 for Dentsply Sirona Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dentsply Sirona, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dentsply Sirona was filed on February 14, 2025 so you should expect the next rating to be made available sometime around February 14, 2026.

While ratings are subjective and will change, the latest Dentsply Sirona (XRAY) rating was a initiated with a price target of $0.00 to $20.00. The current price Dentsply Sirona (XRAY) is trading at is $18.75, which is within the analyst’s predicted range.